- Author:
Wanying WANG
1
;
Fucheng LUO
1
Author Information
- Publication Type:Journal Article
- Keywords: N6-methyladenosine (m6A); central nervous system; central nervous system (CNS) diseases; neurodevelopment
- MeSH: Methylation; Central Nervous System/metabolism*; RNA, Messenger/metabolism*; RNA
- From: Chinese Journal of Biotechnology 2023;39(1):45-59
- CountryChina
- Language:Chinese
- Abstract: There are a variety of post-transcriptional modifications in mRNA, which regulate the stability, splicing, translation, transport and other processes of mRNA, followed by affecting cell development, body immunity, learning and cognition and other important physiological functions. m6A modification is one of the most abundant post-transcriptional modifications widely existing in mRNA, regulating the metabolic activities of RNA and affecting gene expression. m6A modified homeostasis is critical for the development and maintenance of the nervous system. In recent years, m6A modification has been found in neurodegenerative diseases, mental diseases and brain tumors. This review summarizes the role of m6A methylation modification in the development, function and related diseases of the central nervous system in recent years, providing potential clinical therapeutic targets for neurological diseases.